ERCC1 |
ERCC1: DNA excision repair protein ERCC-1 |
ERCC2 |
ERCC2, XPD, XPDC: TFIIH basal transcription factor complex helicase subunit |
0.253 |
Evidence |
|
MCM6 |
MCM6: DNA replication licensing factor MCM6 |
ORC3L |
ORC3L, LATHEO: Origin recognition complex subunit 3 |
0.253 |
Evidence |
|
YY1 |
YY1: Transcriptional repressor protein YY1 |
HIF1AN |
HIF1AN, FIH1: Hypoxia-inducible factor 1 alpha inhibitor |
0.253 |
Evidence |
|
AP4M1 |
AP4M1, MUARP2: AP-4 complex subunit mu-1 |
AP2M1 |
AP2M1, CLAPM1, KIAA0109: AP-2 complex subunit mu-1 |
0.253 |
Evidence |
|
UBAP2 |
IPI00171127 |
TNPO1 |
|
0.253 |
Evidence |
|
RBM6 |
RBM6, DEF3: RNA-binding protein 6 |
ZNF289 |
ZNF289, Nbla10535: GTPase-activating protein ZNF289 |
0.253 |
Evidence |
|
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
CKS1B |
CKS1B, CKS1, PNAS-16, PNAS-143: Cyclin-dependent kinases regulatory subunit 1 |
0.253 |
Evidence |
|
RPL18A |
RPL18A: 60S ribosomal protein L18a |
NSD1 |
NSD1, ARA267: Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 |
0.253 |
Evidence |
|
BIRC1 |
BIRC1, NAIP: Baculoviral IAP repeat-containing protein 1 |
EIF2B1 |
EIF2B1, EIF2BA: Translation initiation factor eIF-2B subunit alpha |
0.253 |
Evidence |
|
SH3GL3 |
IPI00216202 |
DNALI1 |
DNALI1: Axonemal dynein light intermediate polypeptide 1 |
0.253 |
Evidence |
|
DDX3X |
DDX3X, DBX, DDX3: ATP-dependent RNA helicase DDX3X |
CKS2 |
CKS2: Cyclin-dependent kinases regulatory subunit 2 |
0.253 |
Evidence |
|
RPS5 |
RPS5: 40S ribosomal protein S5 |
VDAC3 |
VDAC3: Voltage-dependent anion-selective channel protein 3 |
0.253 |
Evidence |
|
F9 |
F9: Coagulation factor IX precursor |
C9 |
C9: Complement component C9 precursor [Contains: Complement component C9a; Compl |
0.25 |
Evidence |
|
LPA |
LPA: Apolipoprotein(a) precursor |
MBL2 |
MBL2, MBL: Mannose-binding protein C precursor |
0.25 |
Evidence |
|
F10 |
F10: Coagulation factor X precursor |
FGB |
FGB: Fibrinogen beta chain precursor [Contains: Fibrinopeptide B] |
0.25 |
Evidence |
|
SRF |
SRF: Serum response factor |
HIF1A |
HIF1A, MOP1: Hypoxia-inducible factor 1 alpha |
0.25 |
Evidence |
|
PLG |
PLG: Plasminogen precursor |
C9 |
C9: Complement component C9 precursor [Contains: Complement component C9a; Compl |
0.25 |
Evidence |
|
TP53 |
TP53, P53: Cellular tumor antigen p53 |
DAXX |
DAXX, BING2, DAP6: Death domain-associated protein 6 |
0.25 |
Evidence |
|
HPN |
HPN, TMPRSS1: Serine protease hepsin |
MBL2 |
MBL2, MBL: Mannose-binding protein C precursor |
0.25 |
Evidence |
|
CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
OR7C1 |
OR7A5: Olfactory receptor 7A5 |
0.25 |
Evidence |
|
OR6A2 |
OR6A2, OR6A1, OR6A2P: Olfactory receptor 6A2 |
CCL27 |
CCL27, ILC, SCYA27: Small-inducible cytokine A27 precursor |
0.25 |
Evidence |
|
FPRL2 |
FPRL2, FPRH1: FMLP-related receptor II |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.25 |
Evidence |
|
OR7C1 |
OR7A5: Olfactory receptor 7A5 |
CCL17 |
CCL17, SCYA17, TARC: Small-inducible cytokine A17 precursor |
0.25 |
Evidence |
|
GALR3 |
GALR3, GALNR3: Galanin receptor type 3 |
CXCL6 |
CXCL6, GCP2, SCYB6: Small-inducible cytokine B6 precursor |
0.25 |
Evidence |
|
CXCL3 |
CXCL3, GRO3, GROG, SCYB3: Macrophage inflammatory protein 2-beta precursor |
MTNR1B |
MTNR1B: Melatonin receptor type 1B |
0.25 |
Evidence |
|